RESEARCHER PROFILE

Reuven Agami

← Back to Oncode Institute

R

Oncode Institute

Cancer-related molecular mechanisms researchMicroRNA in disease regulationRNA Research and SplicingRNA and protein synthesis mechanismsGenomics and Chromatin Dynamics

Reuven Agami works in Cancer-related molecular mechanisms research, MicroRNA in disease regulation, RNA Research and Splicing, RNA and protein synthesis mechanisms, Genomics and Chromatin Dynamics. Recorded institutional associations include Erasmus MC, The Netherlands Cancer Institute, Oncode Institute.

280Publications
25,594Citations
66H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

    2002 · 4,291 citations
  2. A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors

    2006 · 1,264 citations
  3. Stable suppression of tumorigenicity by virus-mediated RNA interference

    2002 · 1,136 citations
  4. A large-scale RNAi screen in human cells identifies new components of the p53 pathway

    2004 · 1,065 citations
  5. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

    2008 · 975 citations
  6. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation

    2007 · 815 citations
  7. Alternative cleavage and polyadenylation: extent, regulation and function

    2013 · 804 citations
  8. RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA

    2007 · 732 citations
  9. MicroRNA regulation by RNA-binding proteins and its implications for cancer

    2011 · 617 citations
  10. miR-148 targets human DNMT3b protein coding region

    2008 · 577 citations
  11. Interaction of c-Abl and p73α and their collaboration to induce apoptosis

    1999 · 546 citations
  12. eRNAs Are Required for p53-Dependent Enhancer Activity and Gene Transcription

    2012 · 542 citations
  13. Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vector

    2003 · 512 citations
  14. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

    2009 · 512 citations
  15. Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer

    2008 · 474 citations
  16. Transcription Impacts the Efficiency of mRNA Translation via Co-transcriptional N6-adenosine Methylation

    2017 · 433 citations
  17. A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility

    2010 · 402 citations
  18. Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia

    2011 · 398 citations
  19. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9

    2016 · 395 citations
  20. Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage

    2000 · 390 citations
  21. The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites

    2012 · 339 citations
  22. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

    2003 · 310 citations
  23. A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity

    2005 · 273 citations
  24. Tumour-specific proline vulnerability uncovered by differential ribosome codon reading

    2016 · 272 citations
  25. Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer

    2010 · 258 citations

← Return to the university profile